secwatch.observer — SEC 8-K summary
======================================

Issuer:     Eledon Pharmaceuticals, Inc. (ELDN)
CIK:        0001404281
Form:       8-K
Filed at:   2023-09-21T23:59:59+00:00
Accession:  0000950170-23-049046
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Eledon Pharmaceuticals adopts updated director and officer indemnification agreement
--------------------------------------------------------------------------------

- Board approved new form of indemnification agreement for all directors and officers.
- Agreement provides indemnification to the maximum extent permitted by Delaware law.
- New agreement replaces existing indemnification agreements in place with directors and executive officers.
- No departures, elections, or appointments of officers were announced.
- Indemnification rights are in addition to any rights under certificate of incorporation or bylaws.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1404281/000095017023049046/0000950170-23-049046-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1404281/000095017023049046/eldn-20230920.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-049046

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer